Stories
Anjali Labtech Files ‘1,225 Crore IPO to Boost Lab-Grown Diamond Production
C
CNBC TV18•25-09-2026, 16:50
Anjali Labtech Files ‘1,225 Crore IPO to Boost Lab-Grown Diamond Production
- •Anjali Labtech has filed draft papers for an IPO of up to ‘1,225 crore, comprising a fresh issue of ‘925 crore and an Offer for Sale (OFS) of ‘300 crore.
- •The company plans to use the fresh issue proceeds to acquire and install MPCVD machines for increased in-house lab-grown diamond production, construct Anjali Corporate House, repay borrowings, and for general corporate purposes.
- •Promoter-group shareholders Shilpaben Rajanibhai Radadiya, Nehaben Sandipkumar Radadiya, and Madhubhai Samujbhai Radadiya will sell shares in the OFS.
- •Anjali Labtech's profit after tax surged to ‘200.92 crore in FY26, but the company flagged risks including limited operating history, reliance on MPCVD machine sales, customer concentration, and potential US tariffs.
- •Other identified risks include changing consumer perceptions of lab-grown diamonds, seasonal demand fluctuations, capital expenditure requirements, and the absence of directly comparable listed peers.
Key Questions Answered
Anjali Labtech has filed draft papers for an IPO of up to ₹1,225 crore, which consists of a fresh issue of up to ₹925 crore and an offer for sale of up to ₹300 crore.
The company intends to use the net proceeds to buy and install MPCVD machines for diamond manufacturing, construct Anjali Corporate House in Surat, prepay or repay outstanding borrowings, and fund general corporate purposes.
Anjali Labtech's profit after tax increased to ₹200.92 crore in FY26 from ₹146.79 crore in FY25 and ₹90.06 crore in FY24. However, the company flagged key risks including a limited operating history, high customer concentration, heavy reliance on MPCVD machine sales, potential US tariffs, and changing consumer perceptions of lab-grown diamonds.
